Contact
searchSearch
HMP Global
Login

General Psychiatry Topic Center

A person steps onto a scale
News
Neuropsychiatric Side Effects Reported With CB1 Weight-Loss Drug
10/16/2024
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with...
10/16/2024
Psych Congress Network
a cartoon illustration of a man sitting on the floor with this hand on his head, looking distressed.
News
More Than a Fifth of Overdose Decedents Had Non–Substance Mental Health Disorder
09/23/2024
In 2022, 1 in 5 overdose deaths in the United States involved people with mental health disorders (MHD) unrelated to substance use, according to a study published in Morbidity and Mortality Weekly Report.
In 2022, 1 in 5 overdose deaths in the United States involved people with mental health disorders (MHD) unrelated to substance use, according to a study published in Morbidity and Mortality Weekly Report.
In 2022, 1 in 5 overdose deaths...
09/23/2024
Psych Congress Network
A woman sits on the floor looking sad and worried.
News
FDA OKs Digital Therapeutic for Generalized Anxiety Disorder
09/13/2024
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug...
09/13/2024
Psych Congress Network
Bruce Fischer
Q&As
Family of Origin Psychotherapy in Addiction Treatment Creates ‘Beneficial Change,’ Expert Says
09/07/2024
Bruce Fischer, PhD, LP, LMFT, a member of the Cape Cod Symposium 2024 (CCS) faculty, discusses the use of family genograms and motivational interviewing to identify and address intergenerational trauma and addiction within a family system.
Bruce Fischer, PhD, LP, LMFT, a member of the Cape Cod Symposium 2024 (CCS) faculty, discusses the use of family genograms and motivational interviewing to identify and address intergenerational trauma and addiction within a family system.
Bruce Fischer, PhD, LP, LMFT, a...
09/07/2024
Psychiatry & Behavioral Health
From Psychiatry & Behavioral Health
An older woman sits alone
News
New-Onset Anxiety Increases PD Risk in Adults 50 and Older
08/27/2024
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson...
08/27/2024
Neurology
From Neurology
Mental Illness Incidence Increases After COVID-19, But Less So in Vaccinated Adults
News
Mental Illness Incidence Increases After COVID-19, But Less So in Vaccinated Adults
08/26/2024
Rates of most mental illnesses were higher over the 4 weeks after a COVID-19 diagnosis compared with before or without COVID-19, according to cohort study results published in JAMA Psychiatry.
Rates of most mental illnesses were higher over the 4 weeks after a COVID-19 diagnosis compared with before or without COVID-19, according to cohort study results published in JAMA Psychiatry.
Rates of most mental illnesses...
08/26/2024
Psych Congress Network
Cognitive and Psychiatric Burden Substantial Up to 3 Years After Acute COVID-19
News
Cognitive and Psychiatric Burden Substantial Up to 3 Years After Acute COVID-19
08/19/2024
Cognitive and psychiatric symptom trajectories increased over 2 to 3 years after hospitalization for acute COVID-19, according to a study published in Lancet Psychiatry.
Cognitive and psychiatric symptom trajectories increased over 2 to 3 years after hospitalization for acute COVID-19, according to a study published in Lancet Psychiatry.
Cognitive and psychiatric...
08/19/2024
Neurology
From Neurology
fda building sign
News
FDA Rejection of MDMA-Assisted Therapy for PTSD Divides Psychedelic Stakeholders
08/16/2024
The US Food and Drug Administration (FDA) last week rejected the new drug application (NDA) from Lykos Therapeutics for midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD) in conjunction with...
The US Food and Drug Administration (FDA) last week rejected the new drug application (NDA) from Lykos Therapeutics for midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD) in conjunction with...
The US Food and Drug...
08/16/2024
Psych Congress Network
nursing home care
News
CYP2D6-Metabolized Opioids and Antidepressant Concomitant Use Increases Adverse Events in Nursing Home Residents
08/02/2024
Recent findings have shed light on the potential risks associated with the simultaneous use of CYP2D6-metabolized opioids alongside CYP2D6-inhibiting (as opposed to CYP2D6-neutral) antidepressants among older nursing home residents.
Recent findings have shed light on the potential risks associated with the simultaneous use of CYP2D6-metabolized opioids alongside CYP2D6-inhibiting (as opposed to CYP2D6-neutral) antidepressants among older nursing home residents.
Recent findings have shed light...
08/02/2024
Psych Congress Network
Grief-Related Psychiatric Conditions Common Among Bereaved Adults
News
Grief-Related Psychiatric Conditions Common Among Bereaved Adults
07/16/2024
PTSD, MDD, and PGD appear highly prevalent and comorbid among bereaved US adults, particularly those who experienced a traumatic loss of a psychologically close other.
PTSD, MDD, and PGD appear highly prevalent and comorbid among bereaved US adults, particularly those who experienced a traumatic loss of a psychologically close other.
PTSD, MDD, and PGD appear highly...
07/16/2024
Psych Congress Network
Symptom Improvement Found Across Diagnoses With Placebo
News
Symptom Improvement Found Across Diagnoses With Placebo
06/12/2024
Placebo treatment was found to improve symptoms across multiple disorders, though the level of improvement varied from diagnosis to diagnosis, according to a systematic review and meta-analysis published in JAMA Psychiatry. 
Placebo treatment was found to improve symptoms across multiple disorders, though the level of improvement varied from diagnosis to diagnosis, according to a systematic review and meta-analysis published in JAMA Psychiatry. 
Placebo treatment was found to...
06/12/2024
Psych Congress Network

Videos

Dr Craig Chepke
Exclusive Interview
Dr Craig Chepke Appointed Scientific Director of Psych Congress, to Co-Chair Upcoming Elevate Meeting
05/21/2024
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his...
05/21/2024
Psych Congress Network
Rakesh Jain, MD, MPH.
Videos
Balancing Textbook Psychopharmacology With Patient Individuality
02/27/2024

Featuring Rakesh Jain, MD, MPH

Featuring Rakesh Jain, MD, MPH ...
Rakesh Jain, MD, MPH, offers some thoughts on how to balance the technical knowledge of psychopharmacology with the unique circumstances that surround every individual patient. 
Rakesh Jain, MD, MPH, offers some thoughts on how to balance the technical knowledge of psychopharmacology with the unique circumstances that surround every individual patient. 
Rakesh Jain, MD, MPH, offers...
02/27/2024
Psych Congress Network
Rakesh Jain, MD, MPH.
Videos
The Importance of an Exit Plan: Deprescribing in Psychiatry
02/23/2024

Featuring Rakesh Jain, MD, MPH

Featuring Rakesh Jain, MD, MPH ...
Rakesh Jain, MD, MPH, details the concept and importance of de-prescribing in psychiatric clinical practice.
Rakesh Jain, MD, MPH, details the concept and importance of de-prescribing in psychiatric clinical practice.
Rakesh Jain, MD, MPH, details...
02/23/2024
Psych Congress Network
Penn and Williams
Videos
What Mental Health Clinicians Need to Know About Cannabinoids: Psych Congress Elevate Session Preview
05/25/2023
Industry experts preview their session "Is it 4:20 yet? Successful Management of the Cannabis-Using Patient" at Psych Congress Elevate in June.
Industry experts preview their session "Is it 4:20 yet? Successful Management of the Cannabis-Using Patient" at Psych Congress Elevate in June.
Industry experts preview their...
05/25/2023
Psych Congress Network
Saundra Jain and Andrew Penn
Videos
Using Motivational Interviewing to Promote Patient-Centered Care
05/01/2023
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP, discuss how motivational interviewing can be used to establish trust and collaboration with psychiatric patients.
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP, discuss how motivational interviewing can be used to establish trust and collaboration with psychiatric patients.
Saundra Jain, MA, PsyD, LPC, and...
05/01/2023
Psych Congress Network
balfour and winsky
Videos
New 988 Mental Health Crisis Response Hotline Highlights Need for Standardization
06/27/2022
In the conclusion of this 3-part video, Margaret (Margie) E. Balfour, MD, PhD, and Sergeant Jason Winsky, BA, discuss tips for family members and clinicians during a mental health crisis and the upcoming 988 hotline launching July, 2022.
In the conclusion of this 3-part video, Margaret (Margie) E. Balfour, MD, PhD, and Sergeant Jason Winsky, BA, discuss tips for family members and clinicians during a mental health crisis and the upcoming 988 hotline launching July, 2022.
In the conclusion of this 3-part...
06/27/2022
Psych Congress Network
balfour and winsky
Videos
Crisis Response Center Starts Mental Health Treatment Early, Successfully Partners With Community
06/21/2022
Dr Balfour and Sgt Winsky discuss patient care processes at a Tucson Crisis Response Center as well as the community impact of their successful collaboration with law enforcement.
Dr Balfour and Sgt Winsky discuss patient care processes at a Tucson Crisis Response Center as well as the community impact of their successful collaboration with law enforcement.
Dr Balfour and Sgt Winsky...
06/21/2022
Psych Congress Network
Reclaiming Nurses Week
Videos
Reclaiming Nurses Week Part 5: An Open Letter to Our Nurses
05/11/2022
Watch our final video of the series, Reclaiming Nurses Week Part 5: An Open Letter to Our Nurses.
Watch our final video of the series, Reclaiming Nurses Week Part 5: An Open Letter to Our Nurses.
Watch our final video of the...
05/11/2022
Psych Congress Network
Reclaiming Nurses Week
Videos
Reclaiming Nurses Week Part 4: Nurses Mental Health
05/10/2022
Reclaiming Nurses Week Part 4: Nurses Mental Health. Hear the stories of stigma surrounding asking for help.
Reclaiming Nurses Week Part 4: Nurses Mental Health. Hear the stories of stigma surrounding asking for help.
Reclaiming Nurses Week Part 4:...
05/10/2022
Psych Congress Network
Reclaiming Nurses Week
Videos
Reclaiming Nurses Week Part 3: The Solution
05/09/2022
In this installment of Reclaiming Nurses Week, we address The Solution. Nurses share the changes that need to be made and the resources that are currently available.
In this installment of Reclaiming Nurses Week, we address The Solution. Nurses share the changes that need to be made and the resources that are currently available.
In this installment of...
05/09/2022
Psych Congress Network
Jonathan Meyer, MD
Videos
Unpacking Negative Symptoms, Medication Adverse Effects, and Emerging Schizophrenia Treatments
11/11/2024
Jonathan Meyer, MD, offers his clinical insights on schizophrenia management.
Jonathan Meyer, MD, offers his clinical insights on schizophrenia management.
Jonathan Meyer, MD, offers his...
11/11/2024
Psych Congress Network
Desiree Matthews
Schizophrenia Conference Insights
New Class of Medication Offers Innovative Treatment for Schizophrenia Symptoms
11/07/2024
Watch these exclusive insights with Desiree Matthews, PMHNP-BC, to learn how this novel treatment could reshape the landscape of care for adults living with schizophrenia.
Watch these exclusive insights with Desiree Matthews, PMHNP-BC, to learn how this novel treatment could reshape the landscape of care for adults living with schizophrenia.
Watch these exclusive insights...
11/07/2024
Psych Congress Network
Marc Agronin
Videos
Implementing Alzheimer Disease Prevention Practices
11/02/2024
Dr Marc Agronin discusses some easy prevention strategies for Alzheimer disease following his Psych Congress 2024 session "A New Era for Alzheimer’s Disease: Prevention, Early Diagnosis, Effective Intervention."
Dr Marc Agronin discusses some easy prevention strategies for Alzheimer disease following his Psych Congress 2024 session "A New Era for Alzheimer’s Disease: Prevention, Early Diagnosis, Effective Intervention."
Dr Marc Agronin discusses some...
11/02/2024
Psych Congress Network
Christoph Correll, MD.
Videos
Strategies to Manage Adverse Effects From Schizophrenia Treatment
10/28/2024
Christoph Correll, MD, offers clinical guidance for managing adverse affects from schizophrenia treatment, including weight gain and movement disorder
Christoph Correll, MD, offers clinical guidance for managing adverse affects from schizophrenia treatment, including weight gain and movement disorder
Christoph Correll, MD, offers...
10/28/2024
Psych Congress Network
Christoph Correll, MD
Videos
Beyond D2 Receptor Manipulation: Novel Agents for Schizophrenia Treatment
10/16/2024
Christoph Correll, MD, provides a thorough pharmacological overview of the traditional and novel treatments available for schizophrenia.
Christoph Correll, MD, provides a thorough pharmacological overview of the traditional and novel treatments available for schizophrenia.
Christoph Correll, MD, provides...
10/16/2024
Psych Congress Network
Christoph Correll, MD
Videos
Recognizing the Early Indicators of Schizophrenia
10/08/2024
Christoph Correll, MD, reviews some of the key prodromal and accentuated psychotic symptoms that serve as early indicators of schizophrenia.
Christoph Correll, MD, reviews some of the key prodromal and accentuated psychotic symptoms that serve as early indicators of schizophrenia.
Christoph Correll, MD, reviews...
10/08/2024
Psych Congress Network
Desiree Matthews, PMHNP-BC, CEO
Videos
Best Practices for Prescribing Long-Acting Injectable Medications Via Telehealth
09/30/2024
Desiree Matthews, PMHNP-BC, CEO, Different MHP, highlights how providers can integrate medication management into their virtual practices—especially for patients needing long-acting injectable (LAI) antipsychotics.
Desiree Matthews, PMHNP-BC, CEO, Different MHP, highlights how providers can integrate medication management into their virtual practices—especially for patients needing long-acting injectable (LAI) antipsychotics.
Desiree Matthews, PMHNP-BC, CEO,...
09/30/2024
Psych Congress Network
Timothy Wilens, MD
Videos
Managing Life Transitions in ADHD: Why Early Preparation is Critical
09/18/2024
Timothy Wilens, MD, provides practical clinical guidance for supporting patients with ADHD through life transitions.
Timothy Wilens, MD, provides practical clinical guidance for supporting patients with ADHD through life transitions.
Timothy Wilens, MD, provides...
09/18/2024
Psych Congress Network

News

A person steps onto a scale
News
Neuropsychiatric Side Effects Reported With CB1 Weight-Loss Drug
10/16/2024
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with...
10/16/2024
Psych Congress Network
a cartoon illustration of a man sitting on the floor with this hand on his head, looking distressed.
News
More Than a Fifth of Overdose Decedents Had Non–Substance Mental Health Disorder
09/23/2024
In 2022, 1 in 5 overdose deaths in the United States involved people with mental health disorders (MHD) unrelated to substance use, according to a study published in Morbidity and Mortality Weekly Report.
In 2022, 1 in 5 overdose deaths in the United States involved people with mental health disorders (MHD) unrelated to substance use, according to a study published in Morbidity and Mortality Weekly Report.
In 2022, 1 in 5 overdose deaths...
09/23/2024
Psych Congress Network
A woman sits on the floor looking sad and worried.
News
FDA OKs Digital Therapeutic for Generalized Anxiety Disorder
09/13/2024
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug...
09/13/2024
Psych Congress Network
An older woman sits alone
News
New-Onset Anxiety Increases PD Risk in Adults 50 and Older
08/27/2024
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson...
08/27/2024
Neurology
Mental Illness Incidence Increases After COVID-19, But Less So in Vaccinated Adults
News
Mental Illness Incidence Increases After COVID-19, But Less So in Vaccinated Adults
08/26/2024
Rates of most mental illnesses were higher over the 4 weeks after a COVID-19 diagnosis compared with before or without COVID-19, according to cohort study results published in JAMA Psychiatry.
Rates of most mental illnesses were higher over the 4 weeks after a COVID-19 diagnosis compared with before or without COVID-19, according to cohort study results published in JAMA Psychiatry.
Rates of most mental illnesses...
08/26/2024
Psych Congress Network
Cognitive and Psychiatric Burden Substantial Up to 3 Years After Acute COVID-19
News
Cognitive and Psychiatric Burden Substantial Up to 3 Years After Acute COVID-19
08/19/2024
Cognitive and psychiatric symptom trajectories increased over 2 to 3 years after hospitalization for acute COVID-19, according to a study published in Lancet Psychiatry.
Cognitive and psychiatric symptom trajectories increased over 2 to 3 years after hospitalization for acute COVID-19, according to a study published in Lancet Psychiatry.
Cognitive and psychiatric...
08/19/2024
Neurology
fda building sign
News
FDA Rejection of MDMA-Assisted Therapy for PTSD Divides Psychedelic Stakeholders
08/16/2024
The US Food and Drug Administration (FDA) last week rejected the new drug application (NDA) from Lykos Therapeutics for midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD) in conjunction with...
The US Food and Drug Administration (FDA) last week rejected the new drug application (NDA) from Lykos Therapeutics for midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD) in conjunction with...
The US Food and Drug...
08/16/2024
Psych Congress Network
nursing home care
News
CYP2D6-Metabolized Opioids and Antidepressant Concomitant Use Increases Adverse Events in Nursing Home Residents
08/02/2024
Recent findings have shed light on the potential risks associated with the simultaneous use of CYP2D6-metabolized opioids alongside CYP2D6-inhibiting (as opposed to CYP2D6-neutral) antidepressants among older nursing home residents.
Recent findings have shed light on the potential risks associated with the simultaneous use of CYP2D6-metabolized opioids alongside CYP2D6-inhibiting (as opposed to CYP2D6-neutral) antidepressants among older nursing home residents.
Recent findings have shed light...
08/02/2024
Psych Congress Network
Grief-Related Psychiatric Conditions Common Among Bereaved Adults
News
Grief-Related Psychiatric Conditions Common Among Bereaved Adults
07/16/2024
PTSD, MDD, and PGD appear highly prevalent and comorbid among bereaved US adults, particularly those who experienced a traumatic loss of a psychologically close other.
PTSD, MDD, and PGD appear highly prevalent and comorbid among bereaved US adults, particularly those who experienced a traumatic loss of a psychologically close other.
PTSD, MDD, and PGD appear highly...
07/16/2024
Psych Congress Network
Symptom Improvement Found Across Diagnoses With Placebo
News
Symptom Improvement Found Across Diagnoses With Placebo
06/12/2024
Placebo treatment was found to improve symptoms across multiple disorders, though the level of improvement varied from diagnosis to diagnosis, according to a systematic review and meta-analysis published in JAMA Psychiatry. 
Placebo treatment was found to improve symptoms across multiple disorders, though the level of improvement varied from diagnosis to diagnosis, according to a systematic review and meta-analysis published in JAMA Psychiatry. 
Placebo treatment was found to...
06/12/2024
Psych Congress Network
a caregiver speaks with a doctor
News
Caregivers Confirm Usability of Schizophrenia Cognition Rating Scale
11/14/2024
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving...
11/14/2024
Psych Congress Network
Adults Who Smoke Have More Chronic Pain, Use More Opioids
News
Adults Who Smoke Have More Chronic Pain, Use More Opioids
11/07/2024
Rates of chronic pain, prescription opioid use, and severe work limitations rise with the number of cigarettes smoked daily, according to study results published in the American Journal of Preventive Medicine.
Rates of chronic pain, prescription opioid use, and severe work limitations rise with the number of cigarettes smoked daily, according to study results published in the American Journal of Preventive Medicine.
Rates of chronic pain,...
11/07/2024
Psych Congress Network
Patient survey
News
Patient Survey Identifies Barriers to TD Treatment
11/06/2024
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive...
11/06/2024
Psych Congress Network
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
depression stock photo
News
Add-on Lumateperone Eases MDD in Patients With Inadequate Antidepressant Response
11/04/2024
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Adjunctive treatment with the...
11/04/2024
Psych Congress Network
Conference presenter
News
Olanzapine/Samidorphan Demonstrates Favorable Safety Profile in 4-Year Open-Label Study
11/01/2024
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination...
11/01/2024
Psych Congress Network
A person steps onto a scale
News
Neuropsychiatric Side Effects Reported With CB1 Weight-Loss Drug
10/16/2024
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with...
10/16/2024
Psych Congress Network
Increase in Suicidality Associated With FDA Black Box Warning Implementation
News
Increase in Suicidality Associated With FDA Black Box Warning Implementation
10/11/2024
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on...
10/11/2024
Psych Congress Network
An orange prescription container with generic pills spilling out in front of it
News
Masked Taper Plus CBT for Insomnia Effective in Benzodiazepine Discontinuation
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined...
10/10/2024
Psych Congress Network
Bright Light Therapy Effective for Depressive Disorders, May Improve Treatment Response Time
News
Bright Light Therapy Effective for Depressive Disorders, May Improve Treatment Response Time
10/09/2024
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in...
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in...
Bright light therapy (BLT) may...
10/09/2024
Psych Congress Network

Audio

Dr. Michael Myers on Becoming a Doctors' Doctor
Podcasts
Dr. Michael Myers on Becoming a Doctors' Doctor
12/07/2020
Michael Myers, MD, and John Budin, MD, discuss Dr. Myers' recent memoir, how the COVID-19 pandemic is helping medical professionals admit their vulnerabilities, and steps to take when colleagues may need professional help.  
Michael Myers, MD, and John Budin, MD, discuss Dr. Myers' recent memoir, how the COVID-19 pandemic is helping medical professionals admit their vulnerabilities, and steps to take when colleagues may need professional help.  
Michael Myers, MD, and John...
12/07/2020
Psych Congress Network
Combatting Clinician Burnout Through Wellness Practices
Podcasts
Combatting Clinician Burnout Through Wellness Practices
07/27/2020
At Psych Congress Elevate, Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC, discussed clinician burnout and using wellness practices as a possible antidote. In this podcast, she explores the same topic.
At Psych Congress Elevate, Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC, discussed clinician burnout and using wellness practices as a possible antidote. In this podcast, she explores the same topic.
At Psych Congress Elevate, Psych...
07/27/2020
Psych Congress Network
Meeting the Psychiatric Needs of Mental Health Clinicians
Podcasts
Meeting the Psychiatric Needs of Mental Health Clinicians
03/30/2020
In this podcast, Michael F. Myers, MD interviews fellow psychiatrists John Budin, MD, and John S. Tamerin, MD, about mental health professionals living with psychiatric illness and how their needs can be met.
In this podcast, Michael F. Myers, MD interviews fellow psychiatrists John Budin, MD, and John S. Tamerin, MD, about mental health professionals living with psychiatric illness and how their needs can be met.
In this podcast, Michael F....
03/30/2020
Psych Congress Network
Drs Podesta and Carbray
Podcasts
Managing Comorbid Bipolar Disorder & SUD: Treatment and Communication
07/22/2024
Drs Podesta and Carbray examine available treatments, recommended strategies, and how clinicians can better communicate with patients with this comorbidity.
Drs Podesta and Carbray examine available treatments, recommended strategies, and how clinicians can better communicate with patients with this comorbidity.
Drs Podesta and Carbray examine...
07/22/2024
Psych Congress Network
Drs Chepke and Jain
Podcasts
Differentiating Between BPD and Bipolar Disorder in Clinical Practice
05/14/2024

With Rakesh Jain, MD, and Craig Chepke, MD

With Rakesh Jain, MD, and Craig Chepk...
Rakesh Jain, MD, and Craig Chepke, MD, continue their Psych Congress Regionals discussion and examine how to tease apart symptoms of borderline personality disorder from symptoms of bipolar disorder, and how to get to the right diagnosis.
Rakesh Jain, MD, and Craig Chepke, MD, continue their Psych Congress Regionals discussion and examine how to tease apart symptoms of borderline personality disorder from symptoms of bipolar disorder, and how to get to the right diagnosis.
Rakesh Jain, MD, and Craig...
05/14/2024
Psych Congress Network
Drs Chepke and Jain
Podcasts
Managing Adverse Effects and Medication Changes in Bipolar Disorder
05/07/2024
In this podcast, Drs Craig Chepke and Rakesh Jain discuss switching medications and avoiding adverse effects like weight gain in bipolar disorder treatment.
In this podcast, Drs Craig Chepke and Rakesh Jain discuss switching medications and avoiding adverse effects like weight gain in bipolar disorder treatment.
In this podcast, Drs Craig...
05/07/2024
Psych Congress Network
Amber Hoberg, MSN, APRN, PMHNP-BC, Jonathan Meyer, MD, and Saundra Jain, PsyD
Podcasts
Your Questions Answered: Optimizing Tardive Dyskinesia Care
12/05/2023
Clinical experts Amber Hoberg, MSN, APRN, PMHNP-BC, and Jonathan Meyer, MD, answer audience questions on their session, "More than Skin Deep: Examining the Full Impact of Tardive Dyskinesia," presented at Psych Congress Regionals.
Clinical experts Amber Hoberg, MSN, APRN, PMHNP-BC, and Jonathan Meyer, MD, answer audience questions on their session, "More than Skin Deep: Examining the Full Impact of Tardive Dyskinesia," presented at Psych Congress Regionals.
Clinical experts Amber Hoberg,...
12/05/2023
Psych Congress Network
Rakesh Jain, MD, MPH.
Podcasts
Comparing Treatments for Tardive Dyskinesia
11/15/2023
In this podcast, Rakesh Jain, MD, MPH, examines the similarities and differences between the 2 medications approved by the US Food and Drug Administration for the treatment of tardive dyskinesia.
In this podcast, Rakesh Jain, MD, MPH, examines the similarities and differences between the 2 medications approved by the US Food and Drug Administration for the treatment of tardive dyskinesia.
In this podcast, Rakesh Jain,...
11/15/2023
Psych Congress Network
Hoberg and Jain
Podcasts
Navigating and Optimizing Movement Disorder Diagnosis, Treatment
08/03/2023
Nurse Hoberg sheds light on rare presentations of movement disorders as well as in-person and virtual treatment challenges.
Nurse Hoberg sheds light on rare presentations of movement disorders as well as in-person and virtual treatment challenges.
Nurse Hoberg sheds light on rare...
08/03/2023
Psych Congress Network
Podcasts
Evaluating Treatment Response in Major Depressive Disorder
06/02/2023
Mark Zimmerman, MD, professor of psychiatry and human behavior at Brown University examines how clinicians can best measure patient response to medication or treatment.
Mark Zimmerman, MD, professor of psychiatry and human behavior at Brown University examines how clinicians can best measure patient response to medication or treatment.
Mark Zimmerman, MD, professor of...
06/02/2023
Psych Congress Network
Terry Rabinowitz, MD.
Podcasts
Which Psychiatric Disease States Especially Benefit From Telehealth Practice?
05/24/2023
There are no exact substitutes for conducting mental health care in person, but as Terry Rabinowitz, MD, professor of psychiatry and family medicine, Larner College of Medicine, University of Vermont, points out, there are some patients with...
There are no exact substitutes for conducting mental health care in person, but as Terry Rabinowitz, MD, professor of psychiatry and family medicine, Larner College of Medicine, University of Vermont, points out, there are some patients with...
There are no exact substitutes...
05/24/2023
Psych Congress Network
Stacey Flowers, Steven Chan, Craig Chepke, and Amber Hoberg.
Podcasts
Celebrating 7 'Lucky' Years of Psych Congress Elevate: A Preview of Events With Stacey Flowers and the Co-Chairs
05/16/2023
In this podcast hosted by Stacey Flowers, the Psych Congress Elevate 2023 co-chairs share what they're looking forward to at this year's event in Las Vegas.
In this podcast hosted by Stacey Flowers, the Psych Congress Elevate 2023 co-chairs share what they're looking forward to at this year's event in Las Vegas.
In this podcast hosted by Stacey...
05/16/2023
Psych Congress Network
Terry Rabinowitz, MD.
Podcasts
Remaining Mindful of Patient Safety When Practicing Psychiatry via Telehealth
04/25/2023
Terry Rabinowitz, MD, explains how clinicians can remain attentive to patient safety when practicing psychiatry in a virtual setting.
Terry Rabinowitz, MD, explains how clinicians can remain attentive to patient safety when practicing psychiatry in a virtual setting.
Terry Rabinowitz, MD, explains...
04/25/2023
Psych Congress Network

Blogs

Andrew Penn, RN, MS, NP, CNS, APRN-BC
Blog
How New NPs Can Find Mentors
03/04/2022
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains...
03/04/2022
Psych Congress Network
Julie Bailey
Blog
How to Be a Safe Space for Someone
02/08/2022
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey,...
02/08/2022
Psych Congress Network
wellbeing_anxiety_depression
Blog
A Woman's Guide to Overcoming Daily Stress and Improving Overall Well-Being
12/16/2021
This guide provides actionable tips you can implement in everyday life for improved well-being.
This guide provides actionable tips you can implement in everyday life for improved well-being.
This guide provides actionable...
12/16/2021
Psych Congress Network
Athena Robinson
Blog
Using AI to Build a Bridge Between Men and Mental Health Care
10/15/2021
Athena Robinson, PhD, discusses how artificial intelligence can help men overcome the stigma of seeking treatment for mental health disorders.
Athena Robinson, PhD, discusses how artificial intelligence can help men overcome the stigma of seeking treatment for mental health disorders.
Athena Robinson, PhD, discusses...
10/15/2021
Psych Congress Network
Michael Myers
Blog
National Physician Suicide Awareness Day 2021: With Gratitude to the Feists
10/07/2021
Michael Myers, MD, reflects on National Physician Suicide Awareness Day.
Michael Myers, MD, reflects on National Physician Suicide Awareness Day.
Michael Myers, MD, reflects on...
10/07/2021
Psych Congress Network
Dr Agronin
Blog
The Perils of Social Isolation in Older Individuals
06/24/2021
BLOG: I valued the opportunities brought by Telehealth throughout the pandemic, and yet I missed seeing my aging patients in person. Video chats just weren’t as informative or engaging as face-to-face encounters.
BLOG: I valued the opportunities brought by Telehealth throughout the pandemic, and yet I missed seeing my aging patients in person. Video chats just weren’t as informative or engaging as face-to-face encounters.
BLOG: I valued the opportunities...
06/24/2021
Psych Congress Network
Michael_Myers
Blog
It Is Never Too Late
06/04/2021
BLOG: I have kept all the files of my patients who have died by suicide [including] ones under my care when they died & those who were no longer my patients when they took their lives.
BLOG: I have kept all the files of my patients who have died by suicide [including] ones under my care when they died & those who were no longer my patients when they took their lives.
BLOG: I have kept all the files...
06/04/2021
Psych Congress Network
Dr Myers
Blog
How Well-Intentioned Advice Is Suppressing the Doctors of Tomorrow
04/15/2021
Michael Myers, MD, says physicians continue to face pressure to remain silent about mental illness, which leads to hesitancy in seeking help and a worsening of symptoms.
Michael Myers, MD, says physicians continue to face pressure to remain silent about mental illness, which leads to hesitancy in seeking help and a worsening of symptoms.
Michael Myers, MD, says...
04/15/2021
Psych Congress Network
Andrew Penn
Blog
One Year Later: Finding Hope
02/24/2021
BLOG: At the one-year mark of the COVID-19 pandemic, I turn again, as I did in March 2020, to writing to make sense of my world. I am tired, I am frustrated, and I am weary. But, like you, I am still here.
BLOG: At the one-year mark of the COVID-19 pandemic, I turn again, as I did in March 2020, to writing to make sense of my world. I am tired, I am frustrated, and I am weary. But, like you, I am still here.
BLOG: At the one-year mark of...
02/24/2021
Psych Congress Network
Andrew Penn
Blog
Immunization and Insurrection: Will the Better Angels of Our Nature Prevail?
01/09/2021
BLOG: We humans are complex creatures who can hold, Shiva-like, the simultaneous capacity for tremendous creation in one hand and woeful destruction in the other.
BLOG: We humans are complex creatures who can hold, Shiva-like, the simultaneous capacity for tremendous creation in one hand and woeful destruction in the other.
BLOG: We humans are complex...
01/09/2021
Psych Congress Network
marc agronin md
Blog
Alzheimer Disease Prevention: Part 2
07/29/2024
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated...
07/29/2024
Psych Congress Network
Rakesh Amin, MD.
Blog
Treating Schizophrenia: The Importance of Early Identification and Intervention
06/13/2023
Rakesh Amin, MD, discusses the importance of partnering with patients and caregivers to set treatment goals and the importance of introducing long-acting injectables earlier in the treatment of schizophrenia.
Rakesh Amin, MD, discusses the importance of partnering with patients and caregivers to set treatment goals and the importance of introducing long-acting injectables earlier in the treatment of schizophrenia.
Rakesh Amin, MD, discusses the...
06/13/2023
Psych Congress Network
Marc Agronin, MD.
Blog
Alzheimer Disease Prevention
08/30/2022
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section...
08/30/2022
Psych Congress Network
Ed Jones, PhD
Blog
How Our Clinicians Can Help Fix the US Health Care System
07/28/2022
Ed Jones, PhD, discusses the need for a clinical refocusing that includes broad access to psychosocial solutions and ensuring socially informed clinicians can help underserved communities.
Ed Jones, PhD, discusses the need for a clinical refocusing that includes broad access to psychosocial solutions and ensuring socially informed clinicians can help underserved communities.
Ed Jones, PhD, discusses the...
07/28/2022
Psych Congress Network
Ed Jones, PhD
Perspective
The Universal Behavior Model: A Comprehensive Approach to Integrated Care
07/21/2022
Ed Jones, PhD: "We miss this psychosocial aspect of care today...What is missing?  We need psychotherapists based in primary care, often focused on mundane issues rather than the complexities of diagnosis or treatment."
Ed Jones, PhD: "We miss this psychosocial aspect of care today...What is missing?  We need psychotherapists based in primary care, often focused on mundane issues rather than the complexities of diagnosis or treatment."
Ed Jones, PhD: "We miss this...
07/21/2022
Psych Congress Network
Chan_Khan_Digital Mental Health
Blog
Who will use it? How to Get Digital Mental Health Apps Into the Hands of Patients
04/27/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, discuss how to encourage patients to use digital mental health apps.
Steven Chan, MD, MBA, and Burhan...
04/27/2022
Psychiatry & Behavioral Health
Chan_Khan_Digital Mental Health
Blog
How to Navigate Quality Issues With Mental Health Apps
04/21/2022
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan Ahmed Khan, MD, navigating quality issues with digital mental health applications.
Steven Chan, MD, MBA, and Burhan...
04/21/2022
Psychiatry & Behavioral Health
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Blog
How New NPs Can Find Mentors
03/04/2022
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains mentoring, how to find one as an NP, and what to do when you have found a possible mentor. He gives practical advice, questions to ask, and avenues to find the right fit.
Andrew Penn, NP, explains...
03/04/2022
Psych Congress Network
Julie Bailey
Blog
How to Be a Safe Space for Someone
02/08/2022
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey, LCPC, shares her insights on providing a safe space for patients to discuss these social anxieties, as well as tips to share with patients about slowly reintegrating into life after COVID-19.
In this blog, Julie Bailey,...
02/08/2022
Psych Congress Network
major depressive disorder
Blog
The Best and Worst Changes Brought On By the Pandemic
01/31/2022
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy Watson shares her insights about the impact the pandemic has had on mental health and where we go from here.
Mental health advocate, Dorothy...
01/31/2022
Psych Congress Network

News Articles

A person steps onto a scale
News
Neuropsychiatric Side Effects Reported With CB1 Weight-Loss Drug
10/16/2024
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with...
10/16/2024
Psych Congress Network
a cartoon illustration of a man sitting on the floor with this hand on his head, looking distressed.
News
More Than a Fifth of Overdose Decedents Had Non–Substance Mental Health Disorder
09/23/2024
In 2022, 1 in 5 overdose deaths in the United States involved people with mental health disorders (MHD) unrelated to substance use, according to a study published in Morbidity and Mortality Weekly Report.
In 2022, 1 in 5 overdose deaths in the United States involved people with mental health disorders (MHD) unrelated to substance use, according to a study published in Morbidity and Mortality Weekly Report.
In 2022, 1 in 5 overdose deaths...
09/23/2024
Psych Congress Network
A woman sits on the floor looking sad and worried.
News
FDA OKs Digital Therapeutic for Generalized Anxiety Disorder
09/13/2024
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
The United States Food and Drug...
09/13/2024
Psych Congress Network
An older woman sits alone
News
New-Onset Anxiety Increases PD Risk in Adults 50 and Older
08/27/2024
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson...
08/27/2024
Neurology
Mental Illness Incidence Increases After COVID-19, But Less So in Vaccinated Adults
News
Mental Illness Incidence Increases After COVID-19, But Less So in Vaccinated Adults
08/26/2024
Rates of most mental illnesses were higher over the 4 weeks after a COVID-19 diagnosis compared with before or without COVID-19, according to cohort study results published in JAMA Psychiatry.
Rates of most mental illnesses were higher over the 4 weeks after a COVID-19 diagnosis compared with before or without COVID-19, according to cohort study results published in JAMA Psychiatry.
Rates of most mental illnesses...
08/26/2024
Psych Congress Network
Cognitive and Psychiatric Burden Substantial Up to 3 Years After Acute COVID-19
News
Cognitive and Psychiatric Burden Substantial Up to 3 Years After Acute COVID-19
08/19/2024
Cognitive and psychiatric symptom trajectories increased over 2 to 3 years after hospitalization for acute COVID-19, according to a study published in Lancet Psychiatry.
Cognitive and psychiatric symptom trajectories increased over 2 to 3 years after hospitalization for acute COVID-19, according to a study published in Lancet Psychiatry.
Cognitive and psychiatric...
08/19/2024
Neurology
fda building sign
News
FDA Rejection of MDMA-Assisted Therapy for PTSD Divides Psychedelic Stakeholders
08/16/2024
The US Food and Drug Administration (FDA) last week rejected the new drug application (NDA) from Lykos Therapeutics for midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD) in conjunction with...
The US Food and Drug Administration (FDA) last week rejected the new drug application (NDA) from Lykos Therapeutics for midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD) in conjunction with...
The US Food and Drug...
08/16/2024
Psych Congress Network
nursing home care
News
CYP2D6-Metabolized Opioids and Antidepressant Concomitant Use Increases Adverse Events in Nursing Home Residents
08/02/2024
Recent findings have shed light on the potential risks associated with the simultaneous use of CYP2D6-metabolized opioids alongside CYP2D6-inhibiting (as opposed to CYP2D6-neutral) antidepressants among older nursing home residents.
Recent findings have shed light on the potential risks associated with the simultaneous use of CYP2D6-metabolized opioids alongside CYP2D6-inhibiting (as opposed to CYP2D6-neutral) antidepressants among older nursing home residents.
Recent findings have shed light...
08/02/2024
Psych Congress Network
Grief-Related Psychiatric Conditions Common Among Bereaved Adults
News
Grief-Related Psychiatric Conditions Common Among Bereaved Adults
07/16/2024
PTSD, MDD, and PGD appear highly prevalent and comorbid among bereaved US adults, particularly those who experienced a traumatic loss of a psychologically close other.
PTSD, MDD, and PGD appear highly prevalent and comorbid among bereaved US adults, particularly those who experienced a traumatic loss of a psychologically close other.
PTSD, MDD, and PGD appear highly...
07/16/2024
Psych Congress Network
Symptom Improvement Found Across Diagnoses With Placebo
News
Symptom Improvement Found Across Diagnoses With Placebo
06/12/2024
Placebo treatment was found to improve symptoms across multiple disorders, though the level of improvement varied from diagnosis to diagnosis, according to a systematic review and meta-analysis published in JAMA Psychiatry. 
Placebo treatment was found to improve symptoms across multiple disorders, though the level of improvement varied from diagnosis to diagnosis, according to a systematic review and meta-analysis published in JAMA Psychiatry. 
Placebo treatment was found to...
06/12/2024
Psych Congress Network
a caregiver speaks with a doctor
News
Caregivers Confirm Usability of Schizophrenia Cognition Rating Scale
11/14/2024
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving...
11/14/2024
Psych Congress Network
Adults Who Smoke Have More Chronic Pain, Use More Opioids
News
Adults Who Smoke Have More Chronic Pain, Use More Opioids
11/07/2024
Rates of chronic pain, prescription opioid use, and severe work limitations rise with the number of cigarettes smoked daily, according to study results published in the American Journal of Preventive Medicine.
Rates of chronic pain, prescription opioid use, and severe work limitations rise with the number of cigarettes smoked daily, according to study results published in the American Journal of Preventive Medicine.
Rates of chronic pain,...
11/07/2024
Psych Congress Network
Patient survey
News
Patient Survey Identifies Barriers to TD Treatment
11/06/2024
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive...
11/06/2024
Psych Congress Network
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
depression stock photo
News
Add-on Lumateperone Eases MDD in Patients With Inadequate Antidepressant Response
11/04/2024
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Adjunctive treatment with the...
11/04/2024
Psych Congress Network
Conference presenter
News
Olanzapine/Samidorphan Demonstrates Favorable Safety Profile in 4-Year Open-Label Study
11/01/2024
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination...
11/01/2024
Psych Congress Network
A person steps onto a scale
News
Neuropsychiatric Side Effects Reported With CB1 Weight-Loss Drug
10/16/2024
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with...
10/16/2024
Psych Congress Network
Increase in Suicidality Associated With FDA Black Box Warning Implementation
News
Increase in Suicidality Associated With FDA Black Box Warning Implementation
10/11/2024
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on...
10/11/2024
Psych Congress Network
An orange prescription container with generic pills spilling out in front of it
News
Masked Taper Plus CBT for Insomnia Effective in Benzodiazepine Discontinuation
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined...
10/10/2024
Psych Congress Network
Bright Light Therapy Effective for Depressive Disorders, May Improve Treatment Response Time
News
Bright Light Therapy Effective for Depressive Disorders, May Improve Treatment Response Time
10/09/2024
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in...
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in...
Bright light therapy (BLT) may...
10/09/2024
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Sign Up

Psych Congress Network Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use